Aidarex Pharmaceuticals LLC
Aidarex Pharmaceuticals LLC (United States) has no DMF, CEP or site registration linked in our records. 17 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Aidarex Pharmaceuticals LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aidarex-pharmaceuticals-llc
Overview
Aidarex Pharmaceuticals LLC is a privately-held company specializing in the distribution and marketing of pharmaceutical products. The company focuses on providing cost-effective healthcare solutions to a diverse clientele.
Therapeutic areas
FDA compliance signals
17 FDA enforcement records linked to this company.
- recall — Class III2018-08-01
Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
- recall — Class III2018-08-01
Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
- recall — Class III2018-08-01
Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
- recall — Class III2018-05-23
Presence of Foreign Tablets/Capsules
- recall — Class III2017-11-01
Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.
- 4832017-10-20
Results not used for expiration dates, storage cond.
- recall — Class III2017-09-20
Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test
- recall — Class III2016-07-06
Failed Impurities/Degradation Specifications: Out of specification results for unknown impurity.
- recall — Class III2016-06-15
CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.
- recall — Class II2016-06-15
Failed Impurity/Degradation Specifications: Out of specifications for unknown impurity.
- recall — Class II2014-10-29
Presence of Foreign Tablets/Capsules: Tramodol 50 mg tablet has been found in a bottle of Ciprofloxacin 500 mg
- 4832012-02-22
Mfg / Processing Operations Area
- 4832012-02-22
Equipment for Environmental Control
- 4832012-02-22
Cleaning / Sanitizing / Maintenance
- 4832012-02-22
Failing to test for penicillin cross-contamination
- 4832012-02-22
Equipment Design, Size and Location
- 4832012-02-22
Absence of Written Procedures
Is this Aidarex Pharmaceuticals LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.